Thomas H. Krause
Minden, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Refractory Chronic Inflammatory Bowel Disease in Childhood and Adolescence: Options in Primary Non-Response or Secondary Treatment Failure.
Journal: Deutsches Arzteblatt international
Published: July 09, 2026
Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study.
Journal: Journal of Crohn's & colitis
Published: March 28, 2025
Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment.
Journal: Journal of Crohn's & colitis
Published: March 25, 2025
Women with IBD Show Higher Psychophysiological Burden in Comparison to Men with IBD.
Journal: Journal of clinical medicine
Published: November 13, 2024
Switching Vedolizumab from IV to SC Injection in Inflammatory Bowel Disease Patients with Active Disease: Real-World Experience from a German IBD Cohort.
Journal: Journal of clinical medicine
Published: October 05, 2023
Foam fractionation Tags (F-Tags) enabling surfactant-free, activity-preserving recovery of enzymes.
Journal: Applied microbiology and biotechnology
Published: April 06, 2023
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Journal: Inflammatory bowel diseases
Published: January 23, 2023
Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDOIBD -study.
Journal: Alimentary pharmacology & therapeutics
Published: December 23, 2022
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study.
Journal: Inflammatory bowel diseases
Published: June 25, 2022
Rsn-2-mediated directed foam enrichment of β-lactamase.
Journal: Biotechnology journal
Published: May 25, 2022
Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.
Journal: Digestive diseases (Basel, Switzerland)
Published: May 08, 2022
Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease
Journal: Zeitschrift fur Gastroenterologie
Published: November 08, 2021
Last Updated: 09/26/2026